Companies similar to Insight Molecular Diagnostics Inc. (IMDX)
Health Care · NASDAQ
Insight Molecular Diagnostics Inc. (IMDX)'s closest peers include Natera (NTRA), CAREDX INC (CDNA), Labcorp (LH), Quest Diagnostics (DGX) and Thermo Fisher Scientific (TMO). This peer set is drawn from IMDX's enriched company profile and is informational only — not financial advice.
Similar companies
-
NateraNTRAHealth Care
Natera uses proprietary blood-based cell-free DNA technology to deliver personalized genetic diagnostics for oncology, prenatal screening, and organ transplant…
$267.18 (as of 2026-07-21) · market cap $38.1B
-
CAREDX INCCDNAHealth Care
CareDx is the leading provider of genomics-based molecular diagnostics for transplant patients, combining non-invasive cell-free DNA and gene expression…
$38.54 (as of 2026-07-21) · market cap $2.0B
-
LabcorpLHHealth Care
A global diagnostics and drug development laboratory leader that performs 750+ million clinical tests annually and supports 85% of new FDA-approved drugs…
$279.40 (as of 2026-07-21) · market cap $22.9B
-
Quest DiagnosticsDGXHealth Care
Quest Diagnostics is the largest clinical laboratory testing company in the U.S., providing diagnostic insights to healthcare providers, employers, and…
$206.84 (as of 2026-07-21) · market cap $22.8B
-
Thermo Fisher ScientificTMOHealth Care
Thermo Fisher Scientific is a leading global provider of mission-critical laboratory equipment, analytical instrumentation, and scientific services for…
$523.46 (as of 2026-07-21) · market cap $192.1B
Not quite? Describe exactly what you want →
Peers are drawn from IMDX's enriched profile (the same similarity signal the chat uses for "companies like IMDX"). See the full profile: Insight Molecular Diagnostics Inc. (IMDX).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.